Anxo Pharmaceutical Co., Ltd.

TPEX:6677 Stock Report

Market Cap: NT$1.5b

Anxo Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Linquan Yan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Dec 30
These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

Nov 25
Should We Be Cautious About Anxo Pharmaceutical Co., Ltd.'s (GTSM:6677) ROE Of 2.4%?

CEO

Linquan Yan

no data

Tenure